The slow process to success, part 2
Just again a reminder for the weak hand, the pessimist, and the impatient and a summary for the patient.
The RS has been accepted. It took some time before all the legal papers/data were filed/processed/etc, but shares were eventually consolidated on the 23rd. However, this consolidation did not go so smoothly. Different brokers and banks did not consolidate shares/warrants as was intended by CLAS. Robert Farrell, I presume, was not that amused with this mess, and is probably waiting for this mess to be solved, before going ahead with his plan. I mean, would you as an investor like the SP to rise while you’re not able to buy or sell, because your broker messed up, while others can?
In the meantime, however, Robert showed us what R-107 could mean for patients with severe Covid-19 pneumonia in an NR referring to a study done by a successful and excellent institute. CLAS also granted options to directors and officers, and this is usually done in small companies for a job well done before SP will rise, in other words, a sign of good things coming our way.
Now we just have to wait until Robert thinks the mess is solved enough to start “releasing the Kraken”.
And here again, is the stuff we’re waiting for to boost the SP:
-Refund of $700,000-$900,000
-The start of phase I, and probably some other NR’s
-The private placement, and because the price is well above a certain threshold there will be institutional investors involved
-Involvement of institutional investors will drive the SP up
-Announcement of the start of the different cohorts (four in total) in phase I. The start of the next cohort means that the cohort before was successful. This of course will drive up the SP
-Because CLAS is heavily naked shorted, this will be accompanied by a nice and hopefully epic short squeeze.
SP will be well above $1 and probably even more. When phase II is finished, I cannot imagine where the price will be at that moment.
But again, this is just my opinion"